Jubilant Pharmova Ltd. (JUBILANT LIFE SCIENCES )

In News

Jubilant Pharmova Gets USFDA Nod for Commercial Batch Manufacturing at New Spokane Fill-Finish Line - Medical Dialogues

Medical Dialogues - Aug 24, 2026

Jubilant Pharmova’s US facility Line 3 gets FDA nod for commercial production - pharma.economictimes.indiatimes.com

pharma.economictimes.indiatimes.com - Aug 24, 2026

Jubilant Pharmova gets USFDA approval for new fill-and-finish line at Spokane facility - CNBC TV18

CNBC TV18 - Aug 23, 2026

Jubilant Pharmova Q1: Montreal Disruption Hits Margins, But Systematix Stays Bullish — Check Target Price - NDTV Profit

NDTV Profit - Aug 12, 2026

Jubilant Pharmova seeks shareholder nod for ₹2,500 crore NCD issuance - scanx.trade

scanx.trade - Oct 21, 2026

Jubilant Pharmova Q1 profit slumps 45% as margins take hit - Indian Pharma Post

Indian Pharma Post - Aug 11, 2026

Quant MF Sells ₹100 Cr Stake in Jubilant Pharmova - HDFC Sky

HDFC Sky - Oct 13, 2026

Jubilant Generics receives show-cause notice demanding over Rs 105 cr - The Economic Times

The Economic Times - Aug 28, 2026

Jubilant Pharmova's Canada Plant Gets USFDA OAI Status, Remediation Underway - Medical Dialogues

Medical Dialogues - Feb 16, 2026

Jubilant Pharmova's US CMO facility gets 'Voluntary Action Indicated' classification - CNBC TV18

CNBC TV18 - Sep 11, 2026

Jubilant Pharmova Q4 profit declines 21% at ₹119.3 crore - ET Manufacturing

ET Manufacturing - May 23, 2026

USFDA classifies Jubilant Pharmova's Spokane CMO Facility as VAI - Indian Pharma Post

Indian Pharma Post - Sep 12, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment